Citation Impact
Citing Papers
Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
2002
Serum Albumin
1985 Standout
Residence near high voltage facilities and risk of cancer in children.
1993
A pooled analysis of magnetic fields and childhood leukaemia
2000 Standout
Lumbar puncture in pediatric oncology: Conscious sedation vs. general anesthesia
2001
Hyperoxia, reactive oxygen species, and hyperventilation: oxygen sensitivity of brain stem neurons
2004 StandoutNobel
Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas
1992
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group
2004
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Current management and challenges of malignant disease in the CNS in paediatric leukaemia
2008
Recommendations for Quantification Methods During the Performance of a Pediatric Echocardiogram: A Report From the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council
2010 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Alternative splicing in individual aplysia neurons generates neuropeptide diversity
1987 StandoutNobel
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Use of micronutrients and alternative drugs by children with acute lymphoblastic leukemia
1997
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes
2004
Recovery of blood b-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia
1992
New Equations to Estimate GFR in Children with CKD
2009 Standout
Inflammatory Bowel Disease
1991 Standout
Parental employment at time of conception and risk of cancer in offspring
1991
'Vascular Depression' Hypothesis
1997 Standout
Increasing incidence of childhood leukemia in Northwest Italy, 1975–98
2003
Cancer treatment and survivorship statistics, 2012
2012 Standout
The prevalence of complementary/Alternative medicine in cancer
1998 Standout
Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas
2005 StandoutNobel
Recovery of Natural Killer Cells After Chemotherapy for Childhood Acute Lymphoblastic Leukemia and Solid Tumors
1995
The Course of Biological Parameters and 6‐Mercaptopurine Pharmacokinetics during Maintenance Treatment of Children with Acute Lymphoblastic Leukaemia
1990
A Scoring Index for Disease Activity in Canine Inflammatory Bowel Disease
2003 Standout
Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden
2006
A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases
2003
The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's Syndrome
2000
Birth Characteristics, Sibling Patterns, and Acute Leukemia Risk in Childhood: a Population-Based Cohort Study
1997
Down's syndrome
2003 Standout
Men at risk: occupation and male infertility
2004 Standout
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Obesity in children and young people: a crisis in public health
2004 Standout
Chylous ascites: A collective review
2000 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Homocysteine and Atherothrombosis
1998 Standout
Fat distribution and gender differences in serum lipids in men and women from four European communities
1991
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Recovery of Blood T-Cell Subsets After Chemotherapy for Childhood Acute Lymphoblastlc Leukemia
1994
The Danish National Birth Cohort - its background, structure and aim
2001 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
The Biosynthesis of Rat Serum Albumin
1972
Serum Orosomucoid in Ulcerative Colitis
1976
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review
2007
Degree of Fatness after Treatment for Acute Lymphoblastic Leukemia in Childhood1
1999
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
2011
Determination of the Tryptophan Content of Proteins by Ion Exchange Chromatography of Alkaline Hydrolysates
1972 StandoutNobel
Basic anatomical and physiological data for use in radiological protection: reference values
2002 Standout
Hyperleucocytosis in paediatric acute myeloid leukaemia – the challenge of white blood cell counts above 200 × 109/l. The NOPHO experience 1984–2014
2017
Serum Albumin
1970
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor
1983 Standout
Chylous ascites
1969
Geometric method for measuring body surface area: A height-weight formula validated in infants, children, and adults
1978 Standout
Neuropathology of sudden infant death (syndrome): literature review and evidence of a probable apoptotic degenerative cause
2002
Autoantibodies to colonic cells and subcellular fractions in inflammatory bowel disease: Do they exist?
1990
Brain Peptides: What, Where, And Why?
1983 Science
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.
1975
Effects of dynorphin 1–13 on opiate binding and dopamine and GABA uptake in stroked cat brain
1986
Transferrin, biochemistry, physiology and clinical significance
1981
WATER DISTRIBUTION IN THE FOETUS AND NEWBORN INFANT
1983
Homocysteine and Cardiovascular Disease
1998 Standout
Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.
1998
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)
1997
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate.
1991
Lysine residue 199 of human serum albumin is modified by acetylsalicylic acid
1976 StandoutNobel
Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group
2002
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of M. Yssing being referenced
A Population‐Based Study of Childhood Acute Lymphoblastic Leukemia Diagnosed from July 1981 through June 1985 in the Five Nordic Countries
1987
A population‐based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome
1996
A Population‐Based Study of Children with Standard Risk Acute Lymphoblastic Leukemia in the Five Nordic Countries
1989
Incidence of Childhood Cancer in Denmark 1943–1984
1989
Long-term results in children with AML: NOPHO-AML Study Group – report of three consecutive trials
2005
55. Body Composition of Newborn Infants
1965
Transferrin Metabolism in the Nephrotic Syndrome and in Protein-losing Gastroenteropathy
1968
Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non‐high‐risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996
1998
Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia.
1996
IgG and Albumin Turnover in Crohn's Disease
1968
ALBUMIN METABOLISM AND GASTROINTESTINAL PROTEIN LOSS IN CHILDREN WITH NEPHROTIC SYNDROME
1969
Quantitation of Gastrointestinal Protein Loss by Means of Fe59-Labeled Iron Dextran
1968
Hyper-Endorphin Syndrome in a Child with Necrotizing Encephalomyelopathy
1980
Topographic Diagnosis of Gastrointestinal Protein Loss by Means of Radioiodine-labelled Albumin and IgG
1979
Dietary Treatment of Protein‐Losing Enteropathy
1967